Printer Friendly PDF What is Tardive Dyskinesia (TD)? Tardive Dyskinesia (TD) is a drug-induced involuntary movement disorder (DIMD) generally of the tongue, lower face, jaw, and extremities (but sometimes also pharyngeal,...
As part of our ongoing commitment to continuing education, we invite our valued HealthDirect customers to attend complimentary bi-monthly webinars. The session invites, topics and learning objectives are shared via email, allowing attendees to easily register. These webinars feature professional speakers and relevant topics, as well as select continuing education credits.
Printer Friendly PDF What is Tardive Dyskinesia (TD)? Tardive Dyskinesia (TD) is a drug-induced involuntary movement disorder (DIMD) generally of the tongue, lower face, jaw, and extremities (but sometimes also pharyngeal,...
Printer Friendly PDF From the Centers for Medicare & Medicaid Services (CMS) From CMS: §483.45(g) Labeling of Drugs and Biologicals and §483.45(h) Storage of Drugs and Biologicals: “ensure that all drugs and biologicals...
Printer Friendly PDF What is Pharmacogenomics (PGx) testing? PGx is rapidly evolving science focused on how an individual’s genes may affect his or her response to medications. While many patients may metabolize a...
Printer Friendly PDF What are GLP-1 Receptor Agonists (GLP-1 RA)? The GLP-1 Receptor Agonist (GLP-1 RA) medications, also referred to as incretin mimetics or GLP-1 analogs, are biochemical variations of naturally occurring...